1.
Results analysis of maternal serum prenatal screening in the second trimester
15383例孕中期母血清产前筛查结果分析
2.
Relationship of Prenatal Screening Maternal Serum Markers Levels and Obstetric Complications or Pathological Gestation;
产前筛查母血清标志物水平与产科并发症或病理妊娠的研究
3.
The applicability of multiple of median in second trimester maternal serum for prenatal screening
孕中期产前筛查母血清标志物中位数倍数的应用
4.
DELFIA screening in maternal serum of Down′s syndrome and prenatal diagnosis analysis
唐氏综合征母体血清时间分辨荧光免疫筛查和产前诊断分析
5.
Combinational Diagnosis of Serum AFP,β-HCG,PAPP-A in the Prenantal Screening for Down's Syndrome
孕早期血清AFP、β-HCG、PAPP-A联合检测的产前筛查意义
6.
The application of a simple and rapid maternal serum AFP-RIA in prenatal screening
快速母血清甲胎蛋白测定在产前筛选胎儿畸形的应用
7.
Exploratory development for DAZ gene content in pregnancy serum as a new prenatal screening indicator of Down'S syndrome
孕妇血清中DAZ基因含量在21三体产前筛查中的应用
8.
Meta-analysis of prenatal screening for trisomy 21 using nuchal translucency measurement with serum markers
血清学指标结合颈部透明膜产前筛查21-三体综合征的Meta分析
9.
Maternal Weight,Gestational Factors on the Prenatal Screening of Serum Indicators of the ImPact Study
孕妇体重,孕周因素对产前筛查血清学指标的影响
10.
Clinical significance of screening of Down's syndrome and prenatal diagnosis in the second trimester of pregnancy
孕中期唐氏综合征的血清筛查与产前诊断的临床意义
11.
The analyse on clinic treatment of Serological screening and antenatal diagnosis of patients with Down′s syndrome in pregnancy
孕期唐氏综合征的血清筛查和产前诊断临床分析
12.
Investigation on other chromosome abnormalities detected in prenatal serum screening.
产前血清学筛查检出其他染色体异常的分析与探讨
13.
To Evaluate the Clinical Value of Mean Corpuscular Volume on Screening Thalassanemia in Prenatal Diagnosis
应用MCV筛查地中海贫血在产前检查中的价值
14.
The Prospective Clinical Study for Screening the Infants with the High Risk Factor for Cerebral Palsy by Measuring the Lever of Interleukin-6 and Neuron-specificenolase in Premature Serum;
早产儿血清NSE、IL-6水平测定对筛查脑性瘫痪高危儿意义的前瞻性研究
15.
Correlaltion of fetal nuchal translucency thickness with maternal serum markers in screening fetal dysplasia
胎儿颈部软组织厚度及母体血清标记物筛查胎儿异常效果
16.
Experimental Study on Prenatal Screening and Diagnosis of Thalassemia;
地中海贫血的产前筛查与诊断的实验研究
17.
Current methods of screening involve the measurement of serum prostate-specific antigen( PSA) and digital rectal examination followed by biopsy.
现有筛查手段为联合血清前列腺特异性抗原(SA)定和直肠指检。
18.
The Pathological Features of Mass Screening for Prostate Cancer in the Population with Serum Prostate Specific Antigen Level Less Than 4.0ng/ml;
血清PSA<4.0ng/ml的人群中前列腺癌集团筛查的病理学特征